118 related articles for article (PubMed ID: 4020411)
1. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.
Allen JC; Gralla R; Reilly L; Kellick M; Young C
J Clin Oncol; 1985 Aug; 3(8):1136-41. PubMed ID: 4020411
[TBL] [Abstract][Full Text] [Related]
2. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
Craig JB; Powell BL; White DR; Capizzi RL
Oncology; 1987; 44(2):90-2. PubMed ID: 3554086
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
5. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
[TBL] [Abstract][Full Text] [Related]
6. Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
Strum SB; McDermed JE; Streng BR; McDermott NM
J Clin Oncol; 1984 Sep; 2(9):1057-63. PubMed ID: 6470755
[TBL] [Abstract][Full Text] [Related]
7. Dose-ranging antiemetic trial of high-dose oral metoclopramide.
Tyson LB; Gralla RJ; Kris MG; Young CW; Clark RA
Am J Clin Oncol; 1989 Jun; 12(3):239-43. PubMed ID: 2658539
[TBL] [Abstract][Full Text] [Related]
8. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
[TBL] [Abstract][Full Text] [Related]
9. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
10. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.
Graham-Pole J; Weare J; Engel S; Gardner R; Mehta P; Gross S
J Clin Oncol; 1986 Jul; 4(7):1110-3. PubMed ID: 3522818
[TBL] [Abstract][Full Text] [Related]
11. Metoclopramide. A review of antiemetic trials.
Gralla RJ
Drugs; 1983 Feb; 25 Suppl 1():63-73. PubMed ID: 6682376
[TBL] [Abstract][Full Text] [Related]
12. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Kelsen DP; Reilly LK; Groshen S; Bosl GJ; Kalman LA
Cancer; 1985 Feb; 55(3):527-34. PubMed ID: 3880660
[TBL] [Abstract][Full Text] [Related]
13. Metoclopramide as an antiemetic agent in pediatric oncology patients.
Howrie DL; Felix C; Wollman M; Juhl RP; Blatt J
Drug Intell Clin Pharm; 1986 Feb; 20(2):122-4. PubMed ID: 3948688
[TBL] [Abstract][Full Text] [Related]
14. Oral metoclopramide with or without diphenhydramine: potential for prevention of late nausea and vomiting induced by cisplatin.
Grunberg SM; Ehler E; McDermed JE; Akerley WL
J Natl Cancer Inst; 1988 Aug; 80(11):864-8. PubMed ID: 3392746
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of continuous high-dose metoclopramide in patients receiving daily cisplatin infusions.
Saab GA; Ibrahim N; Azouri N
Cancer Treat Rep; 1987 Oct; 71(10):979-80. PubMed ID: 3652059
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
Strum SB; McDermed JE; Liponi DF
J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
18. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
Hayashi Y; Iwasaka T; Hachisuga T; Fukuda K; Tanaka T; Matsuo N; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
[TBL] [Abstract][Full Text] [Related]
19. Five-drug antiemetic combination for cisplatin chemotherapy.
Sridhar KS; Hussein AM; Hilsenbeck S; Cairns V
Cancer Invest; 1992; 10(3):191-9. PubMed ID: 1581829
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
